A therapeutic trial of milacemide in myo
β
P. Brown; P. D. Thompson; J. C. Rothwell; B. L. Day; Prof. C. D. Marsden
π
Article
π
1991
π
John Wiley and Sons
π
English
β 269 KB
π 1 views
We investigated the therapeutic effects of milacemide in seven patients with myoclonus and three patients with the stiff-person syndrome in an open-label trial. Milacemide was initiated at 800 mg/day and was gradually increased to a maximum dosage of 2,400 mg/day. No significant improvement occurred